Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic
ChemMedChem · 2025
DOI: 10.1002/cmdc.202401005 ↗At a glance
Journal article in ChemMedChem, 2025. Written by Maria Pia Lenza and 12 co-authors. Institution: Department of Chemical Sciences and Task Force for Microbiome Studies, University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy. Major MEDLINE topics: Galectin 3, Organoselenium Compounds. Cited 2 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Education, Universities and Research, PRIN MUR 2022.
Abstract (original language)
Chimera‐type galectin‐3 (Gal‐3) is a β‐galactoside‐binding protein containing a single conserved carbohydrate‐recognition domain, crucial in fibrosis and carcinogenesis. Selenium‐based Gal‐3 inhibitors have emerged as promising therapeutic agents, particularly for treating neoplastic diseases. Among them, a seleno‐digalactoside (SeDG) substituted with a benzyl group at position 3 of both saccharide residues (benzyl 3,3′‐seleno‐digalactoside, SeDG‐Bn), attracted considerable attention for its selectivity and potent inhibitory efficacy against Gal‐3. NMR spectroscopy and molecular dynamics simulations were combined to investigate the binding of SeDG‐Bn to Gal‐3 at the molecular level. This approach revealed the recognized epitope, the binding mode within Gal‐3 binding pocket and enabled the generation of a 3D model of the complex. Our findings show that the presence of a single benzyl group establishes hydrophobic contacts with amino acids in Gal‐3 β‐sheets S2 and S3, crucially enhancing the binding affinity compared to unmodified SeDG. The digalactose backbone orientation in Gal‐3 binding site is partially modified by the benzyl group with respect to complexes with lactosamine and SeDG. These results provide valuable insights into the design of more potent and selective inhibitors for Gal‐3, potentially contributing to new therapeutic strategies for conditions such as cancer and fibrosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical Sciences and Task Force for Microbiome Studies, University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy.
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 49, 80131, Napoli, Italy.
- CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore, 486, 80131, Napoli NA.
- Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131, Naples, Italy.
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", Via Vivaldi, 43, Caserta, Italy.
- Department of Physics "Ettore Pancini", University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy.
ORCID profiles: Alba Silipo
Funding
- Ministry of Education
- Universities and Research
- PRIN MUR 2022
- PRIN MUR PNRR 2022
- Italian MUR
- European Union's Horizon 2020
- European Research Council
- Ministry of Higher Education and Scientific Research
Cite
APA
Pia Lenza, M., Di Carluccio, C., Nieto-Fabregat, F., Pirone, L., Russo, R., Di Gaetano, S., Capasso, D., Stornaiuolo, A., Iadonisi, A., Saviano, M., Marchetti, R., Pedone, E., & Silipo, A. (2025). Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic. ChemMedChem. https://doi.org/10.1002/cmdc.202401005
Vancouver
Pia Lenza M, Di Carluccio C, Nieto-Fabregat F, Pirone L, Russo R, Di Gaetano S, et al. Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic. ChemMedChem. 2025. doi:10.1002/cmdc.202401005
BibTeX
@article{PiaLenza2025,
author = {Pia Lenza, Maria and Di Carluccio, Cristina and Nieto-Fabregat, Ferran and Pirone, Luciano and Russo, Rita and Di Gaetano, Sonia and Capasso, Domenica and Stornaiuolo, Alessia and Iadonisi, Alfonso and Saviano, Michele and Marchetti, Roberta and Pedone, Emilia and Silipo, Alba},
title = {Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202401005}
}
EUVIMED